Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study.
- DOI
- 10.1186/s12882-026-05327-9
- Published
- 2026 Aug 31
- Container
- BMC nephrology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12882-026-05327-9,
title = {Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study.},
author = {Huang Y and Meng X and Wu S and Miao X and Qin L and Zhang K and Sun J and Wang J},
year = {2026},
journal = {BMC nephrology},
doi = {10.1186/s12882-026-05327-9},
url = {https://doi.org/10.1186/s12882-026-05327-9}
}RIS
TY - JOUR TI - Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study. AU - Huang Y AU - Meng X AU - Wu S AU - Miao X AU - Qin L AU - Zhang K AU - Sun J AU - Wang J PY - 2026 JO - BMC nephrology DO - 10.1186/s12882-026-05327-9 UR - https://doi.org/10.1186/s12882-026-05327-9 ER -
APA
Y, H., X, M., S, W., X, M., L, Q., K, Z., J, S., & J, W. (2026). Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study.. BMC nephrology. https://doi.org/10.1186/s12882-026-05327-9
Source records
- pubmed · retrieved 2026-09-26T14:32:08.875Z